PARACETAMOL POISONING.pptx

S
PARACETAMOL
POISONING
PARACETAMOL
 Non-steroidal anti-inflammatory drug(NSAID)
 Has analgesic and antipyretic effects but weak anti-inflammatory properties
 Exerts its effects through the inhibition of cyclo-oxygenase (COX)
 COX catalyses the formation of prostaglandins (PGs) and other mediators that
are important in the processing and signaling of pain and control of the
thermoregulatory center of the brain
PHARMACOKINETICS
 Oral acetaminophen has excellent bioavailability
 Peak plasma concentration occur within 30 to 60 minutes
 The half-life in plasma is about 2 hours after therapeutic doses
METABOLISM
 Metabolized in the liver by conjugation with sulfate or glucuronate (90%), and
by CYP2E1 enzymes(5%), and the remainder is secreted unchanged in the
urine(5%)
 The CYP2E1 enzyme pathway is the basis for acetaminophen toxicity
TOXIC DOSE
 More than 7.5 gm (around 15 tablets) – minimal toxicity, severe liver toxicity
if > 15gms (30 tablets)
 In adults toxic dose is 150mg/kg
 In children under 12 years toxic dose is 200mg/kg
 In the presence of chronic liver disease or malnutrition, even 2g of PCM can
be a toxic dose
MECHANISM OF TOXICITY
 When the dose of paracetamol is high the glucuronide and sulfate conjugation
pathways become saturated, and increasing amounts undergo CYP-mediated
Nhydroxylation to form N-acetyl-para- benzoquinoneminine (NAPQI)
 Eliminated rapidly by conjugation with glutathione (GSH) and then further
metabolized to a mercapturic acid and excreted into the urine
 In acetaminophen overdose, hepatocellular levels of GSH become depleted.
 The highly reactive NAPQI metabolite binds covalently to cell
macromolecules, leading to dysfunction of enzymatic systems and structural
and metabolic disarray
 Depletion of intracellular GSH renders the hepatocytes highly susceptible to
oxidative stress and apoptosis.
 Binding covalently to cellular proteins, causes cell death
PARACETAMOL POISONING.pptx
STAGES OF INTOXICATION
 Stage 1 (time of ingestion to 24 hours) : • Patient typically has anorexia,
nausea, vomiting, and diaphoresis • Results of laboratory tests are usually
normal
 Stage 2 (24-72 hours): • Results of laboratory tests begin to be abnormal •
Abnormalities include increases in serum transaminases, bilirubin and PT •
Nephrotoxicity may be evident
 Stage 3 (72 to 96 hours):• Also known as hepatic stage • Severe signs of
hepatotoxicity appear
 This includes: Plasma ALT and AST levels often >10,000 IU/L, increased in PT or
INR Hypoglycemia Lactic acidosis and A total bilirubin concentration above
70umole/l (primarily indirect)
STAGES OF INTOXICATION
 Stage 4 (4 days-2 weeks) : •
 Is the recovery stage
 Patients who survive stage III enter a recovery phase that usually begins by day 4
and is complete by 7 days after overdose
 However, transient renal failure may develop 5-7 days after ingestion (Back pain,
proteinuria, hematuria)
 Complete hepatic recovery may take 3-6 months.Stage 4 (4 days-2 weeks) : • Is the
recovery stage
 Patients who survive stage III enter a recovery phase that usually begins by day 4
and is complete by 7 days after overdose
 However, transient renal failure may develop 5-7 days after ingestion (Back pain,
proteinuria, hematuria) • Complete hepatic recovery may take 3-6 months.
APPROACH TO THE PATIENT
 ABCDE
 History
 Examination
 Investigations
 Initial baseline investigations • LFT, PT/INR, blood glucose, platelet count,
electrolyte, urine routine • Plasma paracetamol level • Determined after 4 hours
of ingestion
MANAGEMENT
 Activated charcoal may be used in patients presenting within 1 hour.
 Antidotes for paracetamol poisoning
 a. N-acetylcysteine (NAC)
 b. Methioinine
 Act by replenishing hepatic glutathione
 N-acetyl cysteine may also repair oxidation damage caused by NAPQI
N-ACETYLCYSTEINE (NAC)
 IV is highly efficacious if administered within 8 hours of the overdose
 Should not be delayed in patients presenting after 8 hours to await a
paracetamol blood concentration result.
 Dose: • 150mg/kg in 200 ml 5% dextrose over 15 minutes • Followed by
50mg/kg in 500 ml 5% dextrose over 4 hours • Followed by 100mg/kg in 1000
ml 5% dextrose over 16 hours
METHIONINE
 An alternative antidote in paracetamol poisoning
 2.5 g orally 4-hourly to a total of four doses
 Less effective, especially after delayed presentation
SUPPORTIVE MANAGMENT
 Give activated charcoal to all patients who present within 1hr post ingestion
 Give vitamin K 10mg to all cases of acute ingestion
THANK YOU
1 sur 15

Recommandé

Paracetamol poisoning par
Paracetamol poisoningParacetamol poisoning
Paracetamol poisoningvivek paul benjamin
975 vues56 diapositives
PARACETAMOL POISIONING.pptx par
PARACETAMOL POISIONING.pptxPARACETAMOL POISIONING.pptx
PARACETAMOL POISIONING.pptxakash chauhan
623 vues15 diapositives
Paracetamol poisoning by Dr. Aryan par
Paracetamol poisoning by Dr. AryanParacetamol poisoning by Dr. Aryan
Paracetamol poisoning by Dr. AryanDr. Aryan (Anish Dhakal)
35.4K vues23 diapositives
Paracetamol overdose par
Paracetamol overdoseParacetamol overdose
Paracetamol overdoseKeerati Sup
239 vues61 diapositives
Acetaminophen overdose par
Acetaminophen overdoseAcetaminophen overdose
Acetaminophen overdoseDr Harikrishna Harindran
816 vues15 diapositives
Medical emergency on paracetamol poisoning par
Medical emergency on paracetamol poisoningMedical emergency on paracetamol poisoning
Medical emergency on paracetamol poisoningIndhu Reddy
25.8K vues40 diapositives

Contenu connexe

Tendances

Peptic ulcer par
Peptic ulcer Peptic ulcer
Peptic ulcer aakriti garg
131 vues33 diapositives
Paracetmol poisoning par
Paracetmol poisoningParacetmol poisoning
Paracetmol poisoningEmir Afif
23.4K vues45 diapositives
Paracetamol poisoning by Sunil Kumar Daha par
Paracetamol poisoning by Sunil Kumar DahaParacetamol poisoning by Sunil Kumar Daha
Paracetamol poisoning by Sunil Kumar Dahasunil kumar daha
5.5K vues17 diapositives
Paracetamol poisoning ml nyein par
Paracetamol poisoning ml nyeinParacetamol poisoning ml nyein
Paracetamol poisoning ml nyeinEhealthMoHS
317 vues20 diapositives
Salicylate poisoning par
Salicylate poisoningSalicylate poisoning
Salicylate poisoningyuva sri sai anumula
13.4K vues22 diapositives
Drug induced liver injury (DILI) and Hepatotoxicity par
Drug induced liver injury (DILI) and HepatotoxicityDrug induced liver injury (DILI) and Hepatotoxicity
Drug induced liver injury (DILI) and HepatotoxicityDr. Ankit Gaur
23.4K vues40 diapositives

Tendances(20)

Paracetmol poisoning par Emir Afif
Paracetmol poisoningParacetmol poisoning
Paracetmol poisoning
Emir Afif23.4K vues
Paracetamol poisoning by Sunil Kumar Daha par sunil kumar daha
Paracetamol poisoning by Sunil Kumar DahaParacetamol poisoning by Sunil Kumar Daha
Paracetamol poisoning by Sunil Kumar Daha
sunil kumar daha5.5K vues
Paracetamol poisoning ml nyein par EhealthMoHS
Paracetamol poisoning ml nyeinParacetamol poisoning ml nyein
Paracetamol poisoning ml nyein
EhealthMoHS317 vues
Drug induced liver injury (DILI) and Hepatotoxicity par Dr. Ankit Gaur
Drug induced liver injury (DILI) and HepatotoxicityDrug induced liver injury (DILI) and Hepatotoxicity
Drug induced liver injury (DILI) and Hepatotoxicity
Dr. Ankit Gaur23.4K vues
Acute Opioid Intoxication in Adults par Ade Wijaya
Acute Opioid Intoxication in Adults Acute Opioid Intoxication in Adults
Acute Opioid Intoxication in Adults
Ade Wijaya4.5K vues
Chronic pancreatitis pathophysiology,management and treatment. newer insights par Kush Bhagat
Chronic pancreatitis pathophysiology,management and treatment. newer insightsChronic pancreatitis pathophysiology,management and treatment. newer insights
Chronic pancreatitis pathophysiology,management and treatment. newer insights
Kush Bhagat18.4K vues
Cas clinique dysfonction erectile et troubles hormonaux vincent hupertan sém... par Vincent H. Hupertan
Cas clinique dysfonction erectile et troubles hormonaux vincent hupertan sém...Cas clinique dysfonction erectile et troubles hormonaux vincent hupertan sém...
Cas clinique dysfonction erectile et troubles hormonaux vincent hupertan sém...
Toxico Overdose Lec07. par Shaikhani.
Toxico Overdose Lec07.Toxico Overdose Lec07.
Toxico Overdose Lec07.
Shaikhani.4.5K vues
5. organophosphate poisoning par SOPHY TC
5. organophosphate poisoning5. organophosphate poisoning
5. organophosphate poisoning
SOPHY TC10.7K vues
Acute poisoning of antidepressants par velspharmd
Acute poisoning of antidepressantsAcute poisoning of antidepressants
Acute poisoning of antidepressants
velspharmd8.9K vues
Drug therapy used in ed,std and aids par Mohit Bharti
Drug therapy used in ed,std and aidsDrug therapy used in ed,std and aids
Drug therapy used in ed,std and aids
Mohit Bharti2.2K vues

Similaire à PARACETAMOL POISONING.pptx

Toxicology par
ToxicologyToxicology
Toxicologyashishnair22
189 vues90 diapositives
paracetmol-poisoning-160215161539 (1).pdf par
paracetmol-poisoning-160215161539 (1).pdfparacetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdfDrYaqoobBahar
6 vues45 diapositives
Hospital pharmacy par
Hospital pharmacyHospital pharmacy
Hospital pharmacySamya Sayantan
1K vues14 diapositives
Anticonvulsant par
AnticonvulsantAnticonvulsant
AnticonvulsantSuman Bhattarai
449 vues37 diapositives
Case Study on Paracetamol toxicity par
Case Study on Paracetamol toxicityCase Study on Paracetamol toxicity
Case Study on Paracetamol toxicityNeeraj Ojha
449 vues19 diapositives
7. ACUTE LIVER FAILURE par
7. ACUTE LIVER FAILURE7. ACUTE LIVER FAILURE
7. ACUTE LIVER FAILUREPratap Tiwari
470 vues22 diapositives

Similaire à PARACETAMOL POISONING.pptx(20)

paracetmol-poisoning-160215161539 (1).pdf par DrYaqoobBahar
paracetmol-poisoning-160215161539 (1).pdfparacetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdf
DrYaqoobBahar6 vues
Case Study on Paracetamol toxicity par Neeraj Ojha
Case Study on Paracetamol toxicityCase Study on Paracetamol toxicity
Case Study on Paracetamol toxicity
Neeraj Ojha449 vues
Adverse drug reaction drugs par Abubakar Fago
Adverse drug reaction drugsAdverse drug reaction drugs
Adverse drug reaction drugs
Abubakar Fago2.3K vues
Nsaids hwuegi1 par hwuegi
Nsaids hwuegi1Nsaids hwuegi1
Nsaids hwuegi1
hwuegi1K vues
Paracetamol toxicity or Acetaminophen toxicity par VHARI5
Paracetamol toxicity  or Acetaminophen toxicityParacetamol toxicity  or Acetaminophen toxicity
Paracetamol toxicity or Acetaminophen toxicity
VHARI555 vues
Acetaminophen poisoning par sahar mirza
Acetaminophen poisoningAcetaminophen poisoning
Acetaminophen poisoning
sahar mirza112 vues
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders par Abel C. Mathew
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Abel C. Mathew10.2K vues
Febuxostat for treatment of chronic gout par Choying Chen
Febuxostat for treatment of chronic goutFebuxostat for treatment of chronic gout
Febuxostat for treatment of chronic gout
Choying Chen5.4K vues

Dernier

Case Study_ AI in the Life Sciences Industry.pptx par
Case Study_ AI in the Life Sciences Industry.pptxCase Study_ AI in the Life Sciences Industry.pptx
Case Study_ AI in the Life Sciences Industry.pptxEmily Kunka, MS, CCRP
33 vues17 diapositives
status epilepticus-management par
status epilepticus-managementstatus epilepticus-management
status epilepticus-managementVamsi Krishna Koneru
9 vues91 diapositives
Epileptogenesis par
EpileptogenesisEpileptogenesis
EpileptogenesisVamsi Krishna Koneru
9 vues50 diapositives
CAPSULE par
 CAPSULE CAPSULE
CAPSULEGanapathi Vankudoth
62 vues24 diapositives
Small Intestine.pptx par
Small Intestine.pptxSmall Intestine.pptx
Small Intestine.pptxMathew Joseph
44 vues50 diapositives
NMP-9.pptx par
NMP-9.pptxNMP-9.pptx
NMP-9.pptxSai Sailesh Kumar Goothy
15 vues46 diapositives

Dernier(20)

Myocardial Infarction Nursing.pptx par Asraf Hussain
Myocardial Infarction Nursing.pptxMyocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptx
Asraf Hussain13 vues
The relative risk of cancer from smoking and vaping nicotine par yfzsc5g7nm
The relative risk of cancer from smoking and vaping nicotine The relative risk of cancer from smoking and vaping nicotine
The relative risk of cancer from smoking and vaping nicotine
yfzsc5g7nm176 vues
VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective par Golden Helix
VarSeq 2.5.0: VSClinical AMP Workflow from the User PerspectiveVarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective
VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective
Golden Helix67 vues
Complications & Solutions in Laparoscopic Hernia Surgery.pptx par Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9106 vues
Top 10 Pharma Companies in Mumbai | Medibyte par Medibyte Pharma
Top 10 Pharma Companies in Mumbai | MedibyteTop 10 Pharma Companies in Mumbai | Medibyte
Top 10 Pharma Companies in Mumbai | Medibyte
Medibyte Pharma17 vues
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences par Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix LifesciencesPharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences
eTEP -RS Dr.TVR.pptx par Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9131 vues
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends par muskansbl01
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
muskansbl0134 vues

PARACETAMOL POISONING.pptx

  • 2. PARACETAMOL  Non-steroidal anti-inflammatory drug(NSAID)  Has analgesic and antipyretic effects but weak anti-inflammatory properties  Exerts its effects through the inhibition of cyclo-oxygenase (COX)  COX catalyses the formation of prostaglandins (PGs) and other mediators that are important in the processing and signaling of pain and control of the thermoregulatory center of the brain
  • 3. PHARMACOKINETICS  Oral acetaminophen has excellent bioavailability  Peak plasma concentration occur within 30 to 60 minutes  The half-life in plasma is about 2 hours after therapeutic doses
  • 4. METABOLISM  Metabolized in the liver by conjugation with sulfate or glucuronate (90%), and by CYP2E1 enzymes(5%), and the remainder is secreted unchanged in the urine(5%)  The CYP2E1 enzyme pathway is the basis for acetaminophen toxicity
  • 5. TOXIC DOSE  More than 7.5 gm (around 15 tablets) – minimal toxicity, severe liver toxicity if > 15gms (30 tablets)  In adults toxic dose is 150mg/kg  In children under 12 years toxic dose is 200mg/kg  In the presence of chronic liver disease or malnutrition, even 2g of PCM can be a toxic dose
  • 6. MECHANISM OF TOXICITY  When the dose of paracetamol is high the glucuronide and sulfate conjugation pathways become saturated, and increasing amounts undergo CYP-mediated Nhydroxylation to form N-acetyl-para- benzoquinoneminine (NAPQI)  Eliminated rapidly by conjugation with glutathione (GSH) and then further metabolized to a mercapturic acid and excreted into the urine  In acetaminophen overdose, hepatocellular levels of GSH become depleted.  The highly reactive NAPQI metabolite binds covalently to cell macromolecules, leading to dysfunction of enzymatic systems and structural and metabolic disarray  Depletion of intracellular GSH renders the hepatocytes highly susceptible to oxidative stress and apoptosis.  Binding covalently to cellular proteins, causes cell death
  • 8. STAGES OF INTOXICATION  Stage 1 (time of ingestion to 24 hours) : • Patient typically has anorexia, nausea, vomiting, and diaphoresis • Results of laboratory tests are usually normal  Stage 2 (24-72 hours): • Results of laboratory tests begin to be abnormal • Abnormalities include increases in serum transaminases, bilirubin and PT • Nephrotoxicity may be evident  Stage 3 (72 to 96 hours):• Also known as hepatic stage • Severe signs of hepatotoxicity appear  This includes: Plasma ALT and AST levels often >10,000 IU/L, increased in PT or INR Hypoglycemia Lactic acidosis and A total bilirubin concentration above 70umole/l (primarily indirect)
  • 9. STAGES OF INTOXICATION  Stage 4 (4 days-2 weeks) : •  Is the recovery stage  Patients who survive stage III enter a recovery phase that usually begins by day 4 and is complete by 7 days after overdose  However, transient renal failure may develop 5-7 days after ingestion (Back pain, proteinuria, hematuria)  Complete hepatic recovery may take 3-6 months.Stage 4 (4 days-2 weeks) : • Is the recovery stage  Patients who survive stage III enter a recovery phase that usually begins by day 4 and is complete by 7 days after overdose  However, transient renal failure may develop 5-7 days after ingestion (Back pain, proteinuria, hematuria) • Complete hepatic recovery may take 3-6 months.
  • 10. APPROACH TO THE PATIENT  ABCDE  History  Examination  Investigations  Initial baseline investigations • LFT, PT/INR, blood glucose, platelet count, electrolyte, urine routine • Plasma paracetamol level • Determined after 4 hours of ingestion
  • 11. MANAGEMENT  Activated charcoal may be used in patients presenting within 1 hour.  Antidotes for paracetamol poisoning  a. N-acetylcysteine (NAC)  b. Methioinine  Act by replenishing hepatic glutathione  N-acetyl cysteine may also repair oxidation damage caused by NAPQI
  • 12. N-ACETYLCYSTEINE (NAC)  IV is highly efficacious if administered within 8 hours of the overdose  Should not be delayed in patients presenting after 8 hours to await a paracetamol blood concentration result.  Dose: • 150mg/kg in 200 ml 5% dextrose over 15 minutes • Followed by 50mg/kg in 500 ml 5% dextrose over 4 hours • Followed by 100mg/kg in 1000 ml 5% dextrose over 16 hours
  • 13. METHIONINE  An alternative antidote in paracetamol poisoning  2.5 g orally 4-hourly to a total of four doses  Less effective, especially after delayed presentation
  • 14. SUPPORTIVE MANAGMENT  Give activated charcoal to all patients who present within 1hr post ingestion  Give vitamin K 10mg to all cases of acute ingestion